Also trades as: FBIO (NASDAQ) · $vol 1M
FBIOP NASDAQ
Fortress Biotech, Inc.
1W: +1.4%
1M: -9.8%
3M: -16.6%
YTD: +66.1%
1Y: +124.5%
3Y: +46.7%
5Y: -12.3%
$16.86
+0.80 (+4.98%)
Weekly Expected Move ±3.6%
$16
$16
$17
$17
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships8
As Filer
counterparties named
3
As Counterparty
mentioned by others
3
Rel. Types
2022-05-16
Earliest Filing
2026-02-23
Latest Filing
partner: 3
acquirer: 3
target: 2
Counterparties (Filed by FBIOP)
8 relationshipsCompanies named in FBIOP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Journey Medical Corporation | DERM | partner | Controlled subsidiary whose net sales are subject to a covenant in the Loan Agreement. | 2026-02-23 | View |
| Checkpoint Therapeutics, Inc. | CHKP | target | Target company in a merger agreement with Sun Pharma, acquired by Fortress Biotech, Inc. | 2025-06-05 | View |
| Sun Pharmaceutical Industries, Inc. | SUNW | acquirer | Acquirer of Checkpoint Therapeutics, Inc. via merger with Snoopy Merger Sub, Inc. | 2025-06-05 | View |
| Snoopy Merger Sub, Inc. | — | partner | Merger subsidiary of Fortress Biotech, Inc. used to acquire Checkpoint Therapeutics, Inc. | 2025-06-05 | View |
| Checkpoint Therapeutics, Inc. | CHKP | target | Target company in a merger agreement to be acquired by Sun Pharma. | 2025-03-10 | View |
| Sun Pharmaceutical Industries, Inc. | SUNW | acquirer | Parent company acquiring Checkpoint Therapeutics, Inc. via a merger. | 2025-03-10 | View |
| Snoopy Merger Sub, Inc. | — | acquirer | Wholly owned subsidiary of Sun Pharma used as the merger vehicle. | 2025-03-10 | View |
| Fortress Biotech, Inc. | FBIOP | partner | Majority-controlled parent of the target and signatory to support, royalty, and transition service agreements. | 2025-03-10 | View |
Mentioned As Counterparty
3 mentionsOther companies that named FBIOP in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ATXI AVENUE THERAPEUTICS, INC. | investor | Acquired 767,085 shares of common stock in a private placement transaction. | 2023-09-08 | View |
| ATXI AVENUE THERAPEUTICS, INC. | target | Transferred majority ownership of Baergic to Avenue Therapeutics in exchange for assumption of liabilities. | 2022-11-08 | View |
| ATXI AVENUE THERAPEUTICS, INC. | partner | Parent company transferring ownership of subsidiary Baergic Bio, Inc. to Avenue Therapeutics, Inc. | 2022-05-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-01 | Other Events | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-23 | Shareholder Vote | View | |
| 2026-05-14 | Earnings Release; Exhibits | View | |
| 2026-03-31 | Earnings Release; Exhibits | View | |
| 2026-03-30 | Other Events; Exhibits | View | |
| 2026-02-23 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin | Agreement | View |
| 2026-01-13 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-15 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-15 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-11-17 | Other Events | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-01 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-16 | Other Events | View | |
| 2025-06-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-05 | Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits | Acquisition | View |
| 2025-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-16 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR